Evolut™ EXPAND TAVR II Pivotal Trial
NCT: NCT05149755 · ACTIVE_NOT_RECRUITING
NCT IDNCT05149755
StatusACTIVE_NOT_RECRUITING
Start Date2022-04-27
Completion2034-12
Brief Summary
Obtain safety and effectiveness data to support indication expansion for the Medtronic TAVR System to include patients with moderate, AS.
Frequently Asked Questions
What is Evolut™ EXPAND TAVR II Pivotal Trial?
Evolut™ EXPAND TAVR II Pivotal Trial is a clinical trial registered under NCT05149755. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT05149755?
The current status of NCT05149755 (Evolut™ EXPAND TAVR II Pivotal Trial) is: ACTIVE_NOT_RECRUITING.
When did Evolut™ EXPAND TAVR II Pivotal Trial start?
Evolut™ EXPAND TAVR II Pivotal Trial started on 2022-04-27.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.